E-MOVE Research News - 2009 Archives

Search Research News

E-MOVE Archives 2009

ID	date	title
1150	1/12/2009	CME Rapid Read Question of the Week: Dyskinesia in late PD
1151	1/13/2009	Tricyclic Antidepressant Superior to SSRI in PD
1152	1/15/2009	CME Question of the Week: Proteasomal Protein Degradation Pathway
1153	1/16/2009	Effects on Autophagy May Link Parkin, alpha-Synuclein in PD Pathogenesis
1154	1/30/2009	Most PD Research Funded by Small Drug Companies
1155	1/31/2009	PD Research is the Focus of Frontline, Tuesday on PBS
1158	2/5/2009	CME Question of the Week: EMG Guidance When Using Botulinum Toxin for the Treatment of Anterocollis Associated with PD
1159	2/5/2009	Gabapentin Prodrug for RLS
1162	2/19/2009	TorsinA Polymorphism Influences Risk of Blepharospasm Spread
1164	3/2/2009	Variant in the LINGO1 Gene Increases Risk of Essential Tremor
1165	3/9/2009	BDNF Allele Doubles Dyskinesia Risk
1166	3/12/2009	Long-Term Results of Initial Pramipexole vs. Levodopa Therapy
1168	4/1/2009	No Role for GBA Mutation in MSA
1169	4/22/2009	Nurr1 Protects Dopamine Neurons from Inflammation
1171	5/8/2009	ET Almost Doubles Dementia Risk (AAN 2009)
1170	5/8/2009	NT201 for Cervical Dystonia, Blepharospasm (AAN 2009)
1174	5/12/2009	New Boxed Warning for BoNT Products; FDA Approves Dysport
1173	5/12/2009	BoNT-B for Sialorrhea in PD (AAN 2009)
1172	5/12/2009	PD Gene Therapy (AAN 2009)
1176	5/13/2009	DYT6 Gene Identified in Both Generalized and Focal Dystonias (AAN 2009)
1177	5/14/2009	Update on Rotigotine (AAN 2009)
1179	5/18/2009	Pregabalin for RLS (AAN 2009)
1180	5/18/2009	Gabapentin Enacarbil for RLS (AAN 2009)
1181	5/20/2009	DBS for Dystonic Cerebral Palsy (AAN 2009)
1182	5/26/2009	Gastric Emptying Delayed in PD Non-Fluctuators (AAN 2009)
1184	5/26/2009	Synuclein Genotype and Head Trauma in PD (AAN 2009)
1186	5/29/2009	Incidence of Spasmodic Dysphonia is Higher than Thought (AAN 2009)
1187	5/29/2009	Long-term Follow-up for BoNT-B in Cervical Dystonia (AAN 2009)
1188	6/1/2009	DBS for Dystonia—Long-term Follow-up (AAN 2009)
1191	6/23/2009	Memantine for PD Dementia (MDS 2009)
1192	6/25/2009	No Benefit from Spheramine Cell Implants in PD (MDS 2009)
1195	7/14/2009	Minocycline Ineffective in Huntington’s Disease (MDS 2009)
1196	7/24/2009	Transplanted Cells Degenerate in Huntington’s Disease Brain
1197	7/27/2009	Lewy Bodies, Cell Death from Cell-to-cell Transmission of Alpha-synuclein
1199	8/4/2009	New Names Approved for Botulinum Toxins
1200	8/7/2009	Novel Neurotrophic Factor for Parkinson’s Disease
1202	8/14/2009	DYT1 Penetrance Linked to Brain Circuitry
1204	8/30/2009	Dopamine Abnormalities in RLS Brain
1207	9/24/2009	ADAGIO Study Published: Possibility of Disease Modification, but Caveats
1208	9/29/2009	Anticholinergics Restore Altered Plasticity in DYT1 Dystonia
1209	10/1/2009	Smaller Posterior Cranial Fossa a Risk Factor for Hemifacial Spasm
1210	10/8/2009	Blacks Less Likely to Receive Treatment for New PD than Whites
1211	10/15/2009	New Gene Variants Account for 15% of All PD
1212	10/27/2009	Family Melanoma History Increases PD Risk
1214	11/10/2009	PD Drivers at Risk When Visual Contrast is Low
1215	11/16/2009	PD Risk from Glucocerebrosidase Mutations Confirmed in Results from 5000+ Patients
1217	11/19/2009	Long-Term STN DBS Reduces Motor Complications in PD
1218	11/23/2009	RLS Gene Increases Risk for Tourette Syndrome
1219	11/25/2009	High Urate Means Slow PD Decline
1220	12/8/2009	Physical Therapy Improves Motor Performance in Cerebellar Ataxia
1221	12/16/2009	TMS Improves Blepharospasm
1222	12/17/2009	Falls in PD Correlate with Cholinergic, not Dopaminergic, Dysfunction
1223	12/23/2009	Multiple Symptom Overlap in REM Disorder and PD
1224	12/24/2009	Topiramate for Tourette Syndrome
1225	12/29/2009	Cognitive Decline Is Associated with Faster Motor Worsening in PD